Drug
Tub 040
Tub 040: highest development phase Phase 1/2, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| TUB-040 NCT06303505 | Phase 1/2 | Ovarian Cancer |
Latest
No recent events.
Follow Tub 040 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.